Senior Leadership

高层领导

• 批准号: 8690273
• 负责人: Dario C Altieri
• 金额: $ 15.83万
• 依托单位: WISTAR INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-03-01 至 2019-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8690273
• 关键词: Advanced Malignant Neoplasm; Appointment; Area; Basic Cancer Research; Budgets; Cancer Biology; Cancer Center; Cancer Center Support Grant; Cancer Research Project; Collaborations; Contracts; Decision Making; Delaware; Development; Disease; Education; Ensure; Faculty; Flow Cytometry; Fox Chase Cancer Center; Funding; Goals; Grant; Growth; HIV; Healthcare; Immunologist; Institutes; Joints; Kaposi Sarcoma; Laboratories; Leadership; Malignant Neoplasms; Mentors; Mission; Neoplasm Metastasis; Physician Executives; Positioning Attribute; Process; Publications; Recruitment Activity; Reporting; Research; Research Infrastructure; Resource Sharing; Role; Science; Strategic Planning; The Wistar Institute; Translational Research; Trustees; Underrepresented Minority; Vision; Work; anticancer research; authority; base; cancer research center director; career development; experience; innovation; medical schools; melanoma; member; multidisciplinary; operation; patient oriented; patient oriented research; professor; programs; tumor microenvironment

The development of a dedicated leadership team was identified as a pivotal priority in the Cancer Center strategic planning process to ensure consultative, transparent and effective decision-making. This was accomplished in the last project period through a combination of new appointments, creation of new leadership positions in the Cancer Center and reconfiguration of existing roles for optimal impact on the cancer research agenda. As part of this reorganization. Dr. Rauscher was appointed as a the sole Deputy Director of the Cancer Center with a codified succession plan should the need arise to replace the current Director, and a second Deputy Director position that was previously filled by Dr. Herlyn was eliminated. Since the introduction of these changes, the senior leadership team has worked well together, guiding an extensive and transparent consultative process that involved every administrative, scientific and educational segment ofthe Cancer Center, and leading a stepwise but decisive implementation ofthe ensuing strategic directives. Together, the senior leaders prioritized changes in the scientific alignment of Programs and Shared Resources, directed an aggressive and successful faculty recruitment effort that brought to the Cancer Center seven new faculty members appointed at all academic ranks, refocused administrative functions and decision-making processes, identified opportunities for translational and patient-oriented cancer research and developed new initiatives to expand education and mentoring, including for underrepresented minorities. Overall, the senior leadership team has catalyzed the introduction of a productive culture of collaboration and scientific exchange that has transformed the Cancer Center in the last budget period, bringing about expansive gains in NCI and cancer-related funding, and significant increase in collaborative, joint publications across the three Cancer Center Programs. This positive trajectory will continue in the next budget period, when the leadership team will guide the largest faculty and facility expansion of the Cancer Center in forty years enabled by the opening of the new Wistar Research Tower

建立一支专门的领导团队被确定为癌症中心战略规划流程的关键优先事项，以确保协商、透明和有效的决策。这是在最后一个项目期间通过新的任命，在癌症中心新的领导职位的创建和现有角色的重新配置对癌症研究议程的最佳影响相结合完成的。作为这次重组的一部分。Rauscher博士被任命为癌症中心的唯一副主任，并制定了一个成文的继任计划，以便在需要时取代现任主任，并取消了以前由Herlyn博士担任的第二个副主任职位。自这些变化引入以来，高层领导团队合作良好，指导了广泛而透明的咨询过程，涉及癌症中心的每个行政，科学和教育部门，并领导逐步但果断地实施随后的战略指令。高级领导人一起优先考虑计划和共享资源的科学调整的变化，指导积极和成功的教师招聘工作，为癌症中心带来了七名新的教师，他们被任命为所有学术级别，重新调整行政职能和决策过程，确定了转化和以患者为导向的癌症研究的机会，并制定了扩大教育和指导的新举措，包括代表性不足的少数群体。总的来说，高级领导团队促进了富有成效的合作和科学交流文化的引入，在上一个预算期内改变了癌症中心，带来了NCI和癌症相关资金的广泛收益，以及三个癌症中心计划的合作，联合出版物的显着增加。这一积极的发展轨迹将在下一个预算期继续下去，届时领导团队将指导癌症中心40年来最大规模的师资和设施扩建，新的Wistar研究塔将启用